Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Huadong Medicine Co., Ltd. clinical trials
Part of China Grand Enterprises, Inc., which holds 41.77% as of 2021-12-31. Source
The registry lists 62 studies whose lead sponsor is Huadong Medicine Co., Ltd. or one of 3 companies grouped under it. 46 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 19, 2026.
Keep track of what changes. Save the Huadong Medicine Co., Ltd. studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Huadong Medicine Co., Ltd..
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.50 studies →Subsidiary
Something wrong?
- Zhejiang Doer Biologics Co., Ltd.9 studies →Acquired — became part of Huadong Medicine Co., Ltd., Apr 2021 · source ↗
Something wrong?
- Sinclair Pharmaceuticals Limited3 studies →Acquired
Something wrong?
Focus areas
Conditions Huadong Medicine Co., Ltd. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 62. Browse all 62 →
- A Phase 2 Study to Evaluate the Efficacy and Safety of DR10624 in Subjects With Moderate Hypertriglyceridemia and Diabetic Kidney DiseaseNot yet recruitingNCT07848880Phase 2
Sponsor listed in the registry: Zhejiang Doer Biologics Co., Ltd. · First submitted after Zhejiang Doer Biologics Co., Ltd. became part of Huadong Medicine Co., Ltd.
- A Study of HDM2017 Combination Therapy in Advanced Colorectal CancerRecruitingNCT07805551Phase 1/2
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Receiving Positive Airway Pressure (PAP) TherapyNot yet recruitingNCT07794397Phase 3
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of HDM1005 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Not Receiving Positive Airway Pressure (PAP) TherapyNot yet recruitingNCT07787260Phase 3
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Efficacy and Safety of Roflumilast Foam 0.3% in Trial Participants With Seborrheic DermatitisNot yet recruitingNCT07683806Phase 3
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- HDM2005 Combination Therapy in Relapsed/Refractory Mantle Cell LymphomaNot yet recruitingNCT07697339Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe HypertriglyceridemiaNot yet recruitingNCT07693777Phase 3
Sponsor listed in the registry: Zhejiang Doer Biologics Co., Ltd. · First submitted after Zhejiang Doer Biologics Co., Ltd. became part of Huadong Medicine Co., Ltd.
- A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe HypertriglyceridemiaNot yet recruitingNCT07680829Phase 3
Sponsor listed in the registry: Zhejiang Doer Biologics Co., Ltd. · First submitted after Zhejiang Doer Biologics Co., Ltd. became part of Huadong Medicine Co., Ltd.
- Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal CancerRecruitingNCT07056777Phase 1/2
Sponsor listed in the registry: Zhejiang Doer Biologics Co., Ltd. · First submitted after Zhejiang Doer Biologics Co., Ltd. became part of Huadong Medicine Co., Ltd.
- A Study of HDM2020 in Patients With Advanced Sq-NSCLCRecruitingNCT07638891Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal CancerNot yet recruitingNCT07621159Phase 1/2
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy SubjectsRecruitingNCT07594847Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Pharmacokinetic Study of HDM1005 Injection in Participants With Impaired Renal Function and Healthy ParticipantsNot yet recruitingNCT07559240Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT06132828Phase 1
Sponsor listed in the registry: Zhejiang Doer Biologics Co., Ltd. · First submitted after Zhejiang Doer Biologics Co., Ltd. became part of Huadong Medicine Co., Ltd.
- A Study of HDM2024 in Participants With Advanced Solid TumorsRecruitingNCT07539285Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple MyelomaRecruitingNCT07529782Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without DiabetesRecruitingNCT07521631Phase 2
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and DigoxinNot yet recruitingNCT07502001Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) InhibitorNot yet recruitingNCT07417306Phase 3
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AloneRecruitingNCT07394114Phase 3
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Study of HDM2006 in Patients With Advanced Solid TumorRecruitingNCT07377591Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and WarfarinRecruitingNCT07331389Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without DiabetesRecruitingNCT07279194Phase 3
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Phase 1 Study of HDM2017 in Advanced Solid TumorsRecruitingNCT07274085Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic ControlRecruitingNCT07244003Phase 4
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseaseNot yet recruitingNCT07116928Phase 4
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes MellitusRecruitingNCT06886126Phase 2
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes MellitusRecruitingNCT07193459Phase 3
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Study to Evaluate the Safety and Effectiveness of Kytogen Defend in Facial Skin Quality Improvement in Adult ParticipantsNot yet recruitingNCT07179198Not applicable
Sponsor listed in the registry: Sinclair Pharmaceuticals Limited · Sinclair Pharmaceuticals Limited — acquired company within the Huadong Medicine Co., Ltd. group
- A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or MetforminRecruitingNCT07109700Phase 2
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell LymphomaRecruitingNCT07124936Phase 1/2
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Study of HDM2012 in Patients With Advanced Solid TumorRecruitingNCT07100249Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Study of HDM2020 in Patients With Advanced Solid TumorsRecruitingNCT07098052Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusRecruitingNCT07082114Phase 3
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese PatientsRecruitingNCT07036172Phase 3
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Study of HDM2005 in Patients With Advanced Solid TumorRecruitingNCT07004296Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Study of HDM1002 in Subjects With And Without Varying Degrees Of Hepatic ImpairementRecruitingNCT06985615Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese AdultsNot yet recruitingNCT06885021Phase 3
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid TumorRecruitingNCT06615193Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy SubjectsNot yet recruitingNCT06608329Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Drug-Drug Interaction (DDI) Study of HDM1002 With Repaglinide, Atorvastatin, Digoxin and Rosuvastatin in Healthy Subjects and Overweight Subjects.Not yet recruitingNCT06601517Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy SubjectsRecruitingNCT06576401Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- HDM1002 Tablets in Chinese Overweight and Obese Adult SubjectsNot yet recruitingNCT06520540Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese AdultsNot yet recruitingNCT06500299Phase 2
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Study to Evaluate the Safety and Effectiveness of Injectable Gel for Correction of Infraorbital Hollowing in Chinese PopulationRecruitingNCT06394076Not applicable
Sponsor listed in the registry: Sinclair Pharmaceuticals Limited · Sinclair Pharmaceuticals Limited — acquired company within the Huadong Medicine Co., Ltd. group
- A Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour DeficitNot yet recruitingNCT06391580Not applicable
Sponsor listed in the registry: Sinclair Pharmaceuticals Limited · Sinclair Pharmaceuticals Limited — acquired company within the Huadong Medicine Co., Ltd. group
- A First in Human (FIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DR10624CompletedNCT05378893Phase 1
Sponsor listed in the registry: Zhejiang Doer Biologics Co., Ltd. · First submitted after Zhejiang Doer Biologics Co., Ltd. became part of Huadong Medicine Co., Ltd.
- A Pharmacokinetic Study of HDM1005 Injection at Different Injection SitesActive, not recruitingNCT07828197Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis SubjectsCompletedNCT07357831Phase 3
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Phase Ib Clinical Study of HDM1005 InjectionCompletedNCT06637020Phase 1
Sponsor listed in the registry: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.